Chongqing Afari Technology (601777.SH) started off strong in 2026 with a dual increase in revenue and profits. The "AI+ vehicle" strategy is accelerating value reshaping.
On April 27, 2026, Qianli Technology (601777.SH) released its first quarter financial report for 2026.
On April 27, 2026, Chongqing Afari Technology (601777.SH) released its financial report for the first quarter of 2026. During the reporting period, the company achieved operating income of 2.361 billion yuan, a year-on-year increase of 30.69%; net profit attributable to the shareholders of the listed company reached 0.48 billion yuan, a year-on-year increase of 141.31%. With the continuous optimization of its business structure, the automotive and motorcycle business has made steady progress, while the AI technology business is growing rapidly, significantly improving the overall operating quality of the company. The double growth in revenue and net profit marks a comprehensive acceleration of the implementation of Chongqing Afari Technology's "AI + Car" strategy.
Currently, Chongqing Afari Technology is accelerating its transition from AI strategic layout to the commercial implementation stage. The company has formulated a clear strategy for commercializing AI and a roadmap for technological development. To this end, Chongqing Afari Technology is continuing to increase its research and development investment, accelerating the pace of transformation into a technology company.
Related Articles

GENFLEET-B(02595): The subject, products, and disputed issues related to the letter issued by Rev Med have nothing to do with the company.

RIMAG GROUP (02522) x Yehe Medical Strategic Release of Super Smart CT Brain Imaging Intelligence: from "Image Recognition" to "Image Understanding", medical imaging AI welcomes killer-level applications at the "examination project level".

EDVANTAGE GROUP (00382) releases its interim performance and achieves a revenue of 1.186 billion yuan during the period.
GENFLEET-B(02595): The subject, products, and disputed issues related to the letter issued by Rev Med have nothing to do with the company.

RIMAG GROUP (02522) x Yehe Medical Strategic Release of Super Smart CT Brain Imaging Intelligence: from "Image Recognition" to "Image Understanding", medical imaging AI welcomes killer-level applications at the "examination project level".

EDVANTAGE GROUP (00382) releases its interim performance and achieves a revenue of 1.186 billion yuan during the period.






